Abstract

Despite the importance of radiation therapy as a non-surgical treatment for non-small cell lung cancer (NSCLC), radiation resistance has always been a concern, due to poor patient response and prognosis. Therefore, it is crucial to uncover novel targets to enhance radiotherapy and investigate the mechanisms underlying radiation resistance. Previously, we demonstrated that NRP1 was connected to radiation resistance in NSCLC cells. In the present study, bioinformatics analysis of constructed radiation-resistant A549 and H1299 cell models revealed that transcription coactivator YAP is a significant factor in cell proliferation and metastasis. However, there has been no evidence linking YAP and NRP1 to date. In this research, we have observed that YAP contributes to radiation resistance in NSCLC cells by stimulating cell proliferation, migration, and invasion. Mechanistically, YAP dephosphorylation after NSCLC cell radiation. YAP acts as a transcription co-activator by binding to the transcription factor TEAD4, facilitating TEAD4 to bind to the NRP1 promoter region and thereby increasing NRP1 expression. NRP1 has been identified as a new target gene for YAP/TEAD4. Notably, when inhibiting YAP binds to TEAD4, it inhibits NRP1 expression, and Rescue experiments show that YAP/TEAD4 influences NRP1 to regulate cell proliferation, metastasis and leading to radiation resistance generation. According to these results, YAP/TEAD4/NRP1 is a significant mechanism for radioresistance and can be utilized as a target for enhancing radiotherapy efficacy.

Details

Title
Radiation-induced YAP/TEAD4 binding confers non-small cell lung cancer radioresistance via promoting NRP1 transcription
Author
Wang, Mingwei 1 ; Yi, Junxuan 1   VIAFID ORCID Logo  ; Gao, Hui 2 ; Wei, Xinfeng 1 ; Xu, Weiqiang 1 ; Zhao, Mingqi 1 ; Zhao, Mengdie 1 ; Shen, Yannan 1 ; Wang, Zhicheng 1 ; Wu, Ning 3 ; Wei, Wei 4 ; Jin, Shunzi 1   VIAFID ORCID Logo 

 Jilin University, NHC Key Laboratory of Radiobiology, School of Public Health, Changchun, China (GRID:grid.64924.3d) (ISNI:0000 0004 1760 5735) 
 Jilin University, NHC Key Laboratory of Radiobiology, School of Public Health, Changchun, China (GRID:grid.64924.3d) (ISNI:0000 0004 1760 5735); The First Hospital of Jilin University, Department of Orthopedics, Changchun, China (GRID:grid.430605.4) (ISNI:0000 0004 1758 4110) 
 China-Japan Union Hospital of Jilin University, Department of Radiation Oncology, Changchun, China (GRID:grid.64924.3d) (ISNI:0000 0004 1760 5735) 
 Chinese PLA General Hospital, Department of Radiotherapy, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894) 
Pages
619
Publication year
2024
Publication date
Aug 2024
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3097304770
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.